202 related articles for article (PubMed ID: 20950249)
1. Contribution of intangible costs to the economic burden of multiple sclerosis.
Wundes A; Brown T; Bienen EJ; Coleman CI
J Med Econ; 2010; 13(4):626-32. PubMed ID: 20950249
[TBL] [Abstract][Full Text] [Related]
2. Costs and quality of life of multiple sclerosis in Switzerland.
Kobelt G; Berg J; Lindgren P; Gerfin A; Lutz J
Eur J Health Econ; 2006 Sep; 7 Suppl 2():S86-95. PubMed ID: 17310338
[TBL] [Abstract][Full Text] [Related]
3. Costs and quality of life of multiple sclerosis in Austria.
Kobelt G; Berg J; Lindgren P; Plesnilla C; Baumhackl U; Berger T; Kolleger H; Vass K
Eur J Health Econ; 2006 Sep; 7 Suppl 2():S14-23. PubMed ID: 17310339
[TBL] [Abstract][Full Text] [Related]
4. Costs and quality of life of multiple sclerosis in Italy.
Kobelt G; Berg J; Lindgren P; Battaglia M; Lucioni C; Uccelli A
Eur J Health Econ; 2006 Sep; 7 Suppl 2():S45-54. PubMed ID: 17310336
[TBL] [Abstract][Full Text] [Related]
5. Costs and quality of life for patients with multiple sclerosis in Belgium.
Kobelt G
Eur J Health Econ; 2006 Sep; 7 Suppl 2():S24-33. PubMed ID: 17318662
[TBL] [Abstract][Full Text] [Related]
6. Costs and quality of life of multiple sclerosis in Germany.
Kobelt G; Berg J; Lindgren P; Elias WG; Flachenecker P; Freidel M; König N; Limmroth V; Straube E
Eur J Health Econ; 2006 Sep; 7 Suppl 2():S34-44. PubMed ID: 17310337
[TBL] [Abstract][Full Text] [Related]
7. Costs and quality of life in multiple sclerosis in The Netherlands.
Kobelt G; Berg J; Lindgren P; Anten B; Ekman M; Jongen PJ; Polman C; Uitdehaag B
Eur J Health Econ; 2006 Sep; 7 Suppl 2():S55-64. PubMed ID: 17310343
[TBL] [Abstract][Full Text] [Related]
8. Costs and quality of life of multiple sclerosis in Spain.
Kobelt G; Berg J; Lindgren P; Izquierdo G; Sánchez-Soliño O; Pérez-Miranda J; Casado MA;
Eur J Health Econ; 2006 Sep; 7 Suppl 2():S65-74. PubMed ID: 17310340
[TBL] [Abstract][Full Text] [Related]
9. Costs and quality of life of multiple sclerosis in Sweden.
Berg J; Lindgren P; Fredrikson S; Kobelt G
Eur J Health Econ; 2006 Sep; 7 Suppl 2():S75-85. PubMed ID: 17310342
[TBL] [Abstract][Full Text] [Related]
10. An approach to estimating the intangible costs of multiple sclerosis according to disability in Catalonia, Spain.
Casado V; Romero L; Gubieras L; Alonso L; Moral E; Martinez-Yelamos S; Martinez-Yelamos A; Carmona O; Arbizu T
Mult Scler; 2007 Jul; 13(6):800-4. PubMed ID: 17613609
[TBL] [Abstract][Full Text] [Related]
11. [The costs of a multiple sclerosis relapse in Catalonia (Spain)].
Casado V; Martinez-Yelamos S; Martinez-Yelamos A; Carmona O; Alonso L; Romero L; Moral E; Arbizu T
Neurologia; 2006 Sep; 21(7):341-7. PubMed ID: 16977554
[TBL] [Abstract][Full Text] [Related]
12. The cost of multiple sclerosis in Australia.
Taylor B; McDonald E; Fantino B; Sedal L; MacDonnell R; Pittas F; Groom T; Beresniak A
J Clin Neurosci; 2007 Jun; 14(6):532-9. PubMed ID: 17430777
[TBL] [Abstract][Full Text] [Related]
13. [Multiple sclerosis: cost of the illness].
Tissot E; Woronoff-Lemsi MC
Rev Neurol (Paris); 2001 Sep; 157(8-9 Pt 2):1169-74. PubMed ID: 11787352
[TBL] [Abstract][Full Text] [Related]
14. Costs and quality of life in multiple sclerosis patients with spasticity.
Svensson J; Borg S; Nilsson P
Acta Neurol Scand; 2014 Jan; 129(1):13-20. PubMed ID: 23683163
[TBL] [Abstract][Full Text] [Related]
15. Quantifying the role of natalizumab in health and economic outcomes in multiple sclerosis.
Brandes DW; Shaya FT; Pill MW
Am J Manag Care; 2010 Jun; 16(6 Suppl):S171-7. PubMed ID: 20615053
[TBL] [Abstract][Full Text] [Related]
16. Health status and costs of ambulatory patients with multiple sclerosis in Hungary.
Péntek M; Gulácsi L; Rózsa C; Simó M; Iljicsov A; Komoly S; Brodszky V
Ideggyogy Sz; 2012 Sep; 65(9-10):316-24. PubMed ID: 23126217
[TBL] [Abstract][Full Text] [Related]
17. A cost evaluation of multiple sclerosis.
Battaglia MA; Zagami P; Uccelli MM
J Neurovirol; 2000 May; 6 Suppl 2():S191-3. PubMed ID: 10871812
[TBL] [Abstract][Full Text] [Related]
18. Costs and quality of life in multiple sclerosis in Europe: method of assessment and analysis.
Kobelt G; Berg J; Lindgren P; Jönsson B
Eur J Health Econ; 2006 Sep; 7 Suppl 2():S5-13. PubMed ID: 17310344
[TBL] [Abstract][Full Text] [Related]
19. The societal burden of osteoporosis in Sweden.
Borgström F; Sobocki P; Ström O; Jönsson B
Bone; 2007 Jun; 40(6):1602-9. PubMed ID: 17433804
[TBL] [Abstract][Full Text] [Related]
20. The effects of economic disadvantage on psychological well-being and quality of life among people with multiple sclerosis.
McCabew MP; De Judicibus M
J Health Psychol; 2005 Jan; 10(1):163-73. PubMed ID: 15576507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
